today show glp-1 drugs, like Ozempic and Wegovy, offer an “extraordinary opportunity to change…the health of our country,” Dr. David Kessler says, but he cautions that “there is no endgame” for getting off of The GLP-1 Revolution: The Science,

Future research should focus on long-term outcomes, optimal treatment protocols, patient selection criteria, and strategies to ensure equitable access

183 Rodrguez-SerranoM.Romero-PuertasM

Journal of the neurological sciences

Genetic testing for UGT1A1, GSTM1, GSTT1, NAT2, COMT, and SULT1A1 variants helps identify fixed (non-modifiable) conjugation bottlenecks that require lifelong compensatory strategies

Within that group, the ideal phentermine candidate is an adult whose cardiovascular system can tolerate a stimulant normotensive or well-controlled, without symptomatic heart disease, and without the contraindications listed above

It was postulated that the coordination between plastids and mitochondria might occur by the dual targeting rather than subtle retrograde signaling (Millar et al., 2001